AEROLATE III Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aerolate Iii, and when can generic versions of Aerolate Iii launch?
Aerolate Iii is a drug marketed by Fleming Pharms and is included in one NDA.
The generic ingredient in AEROLATE III is theophylline. There are thirty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the theophylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aerolate Iii
A generic version of AEROLATE III was approved as theophylline by RHODES PHARMS on September 1st, 1982.
Summary for AEROLATE III
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 171 |
| Patent Applications: | 7,863 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | AEROLATE III at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for AEROLATE III
US Patents and Regulatory Information for AEROLATE III
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fleming Pharms | AEROLATE III | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 085075-003 | Nov 24, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
